By Melissa Davies
New Zealanders born with missing limbs because of a drug given to their mothers are campaigning for compensation from the Government.
Thalidomide survivors have been spurred on by a British announcement that victims there will get around $45 million over the next three years.
Barry de Geest was born with no arms and deformed legs. To get around he relies on his $30,000 wheelchair and dog, Bentley.
Mr de Geest calls himself a thalidomide survivor.The drug, also called debendox, was prescribed to pregnant women in the 1950-60s to help with morning sicknes - but their babies were born with missing limbs and other disabilities.
Mr de Geest is not entitled to ACC help as the condition is a birth defect.
“I look at people on ACC and think how lucky they are because they had an accident, it's a silly way to look at it but that's the way it is,” he says.
Thalidomide survivors in the UK have today won an apology and the promise of millions of dollars in compensation.
Guy Tweedy, of the UK Thalidomide Trust, says the compensation is a huge boost.
“It's great news for a lot of thalidomiders because really they are struggling,” he says.
“There's unmet needs and this money will go some way to helping them a big deal in the next three years.”
Inspired by the British progress, Mr de Geest is organising a meeting for victims in New Zealand. He has tracked down only 10 so far but knows there are up to 10,000 worldwide.
Some sufferers were compensated a small amount in the 1960s, but Mr de Geest says help is more important now as they grow older.
“I used to walk, I also could look after, dress myself and things like that - whereas now I need support,” he says.
Thalidomide is still prescribed for people who suffer from leprosy and to treat some forms of cancer.
However its medical notes now come with a very clear warning for pregnant women. It states that even a single dose can result in severe life-threatening birth defects.
The Ministry of Health says there are now strict controls on thalidomide use in New Zealand.
3 News